Vertical ancestries and horizontal risks: Hepatitis B and AIDS

Heredity and Infection: The History of Disease Transmission

Volumn , Issue , 2012, Pages 311-325

  Stanton, Jennifer ^a   Berridge, Virginia ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84894924680     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.4324/9780203378823-19     Document Type: Chapter

References (21)

1. A.C. Allison, B.S. Blumberg, and W. ap Rees, ‘Haptoglobin types in British, Spanish Basque and Nigerian African populations’ Nature (1958) 181: 824-25.
2. A.C. Allison, and B.S. Blumberg, ‘An isoprecipitation reaction distinguishing human serum protein types’ Lancet (1961) i: 634-37.
3. J. Ashton, and H. Seymour, The new public health: the Liverpool experience (Milton Keynes: Open University Press, 1988) pp. 86-87 and 118-20.
4. H.K. Beecher, ‘Ethics and clinical research’ New England Journal of Medicine (1966) 274: 1354-60.
5. V. Berridge, ‘AIDS in the U.K. The Making of Policy, 1981-1994' (Oxford: Oxford University Press, 1996).
6. B.S. Blumberg, ‘Australia antigen and the biology of hepatitis B’, Nobel Lecture, December 13 1976, in Les Prix Nobel en 1976 (Stockholm: Imprimerie Royale P.A. Norstedt & Söner, 1977).
7. B.S. Blumberg, A.C. Allison, and W. Garry, ‘The haptoglobins and hemoglobins of Alaskan Eskimos and Indians’ Annals of Human Genetics (1959) 23: 349-56.
8. B.S. Blumberg et al., ‘A serum antigen (Australia antigen) in Down’s syndrome leukemia and hepatitis’ Annals of Internal Medicine (1967) 66: 924-31.
9. W.B. Clee, and P.R. Hunter, ‘Hepatitis B in general practice: epidemiology, clinical and serological features, and control’ British Medical Journal (1987) 295: 530-32; diagram on p. 531.
10. K.M. de Cock, ‘AIDS: an old disease from Africa?' British Medical Journal (1984) 289: 306-08, 1454-55.
11. C. Douglas, The houseman’s tale (London: Hutchinson, 1975).
12. E.B. Ford, Genetics for medical students (London: Metheun, 1956).
13. W.T. London, and B.S. Blumberg, ‘Comments on the role of epidemiology in the investigation of hepatitis B virus’ Epidemiologic Reviews (1985) 7: 59-79.
14. J.E. Maynard, ‘Hepatitis B: global importance and need for control’ Vaccine (1990) 8, Supplement, S18.
15. W. Muraskin, The War Against Hepatitis B: A History of the International Task Force on Hepatitis B Immunization (Philadelphia: University of Pennsylvania Press, 1995).
16. G.M. Oppenheimer, ‘In the eye of the storm; the epidemiological construction of AIDS’ in E. Fee and D. Fox (eds.), AIDS: The Burdens of History (Berkeley: University of California Press, 1988) pp. 267-300.
17. S. Polakoff, ‘Immunisation of infants at high risk of hepatitis B’ British Medical Journal (1982) 285.
18. A.M. Prince, ‘Prevalence of serum-hepatitis-related antigen (SH) in different geographic regions’ American Journal of Tropical Medicine and Hygiene (1970) 19: 872-79.
19. C. Rosenberg, ‘Disease and social order in America: Perceptions and expectations’ in C. Rosenberg (ed.), Explaining Epidemics and Other studies in the History of Medicine (Cambridge: Cambridge University Press, 1992) pp. 258-77.
20. J. Stanton, ‘What makes vaccine policy? The case of hepatitis B’ Social History of Medicine (1994) 7: 427-46.
21. J. Stanton, ‘Health policy and medical research: hepatitis B in the UK since the 1940s’, PhD thesis, University of London, 1995, chapter 2.